244 related articles for article (PubMed ID: 23468260)
21. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal stromal tumor (GIST) in southern Taiwan: a clinicopathologic study of 93 resected cases.
Li CF; Chuang SS; Lu CL; Lin CN
Pathol Res Pract; 2005; 201(1):1-9. PubMed ID: 15807305
[TBL] [Abstract][Full Text] [Related]
23. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
Sarlomo-Rikala M; Kovatich AJ; Barusevicius A; Miettinen M
Mod Pathol; 1998 Aug; 11(8):728-34. PubMed ID: 9720500
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal stromal tumors express ras oncogene: a potential role for diagnosis and treatment.
Blair SL; Al-Refaie WB; Wang-Rodriguez J; Behling C; Ali MW; Moossa AR
Arch Surg; 2005 Jun; 140(6):543-7; discussion 547-8. PubMed ID: 15967901
[TBL] [Abstract][Full Text] [Related]
25. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
26. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract.
Rossi G; Valli R; Bertolini F; Marchioni A; Cavazza A; Mucciarini C; Migaldi M; Federico M; Trentini GP; Sgambato A
Histopathology; 2005 May; 46(5):522-31. PubMed ID: 15842634
[TBL] [Abstract][Full Text] [Related]
27. Use of tissue microarrays and immunohistochemistry to standardize the diagnosis of gastrointestinal stromal tumors.
Ogino J; Asanuma H; Sakurai S; Matsuno Y; Miyokawa N; Yamashiro K; Fukazawa Y; Muraoka S; Iwaki Y; Kondo N; Hasegawa T
Pathol Int; 2010 Nov; 60(11):707-13. PubMed ID: 20946519
[TBL] [Abstract][Full Text] [Related]
28. [Differential diagnosis and treatment of esophageal stromal tumors and smooth muscle tumors].
Zhang X; Rong TH; Wu QL; Fu JH; Long H; Zhang LJ; Ma GW; Su XD; Li XD; Wang DF; Hu Y; Yang H
Ai Zheng; 2006 Jul; 25(7):901-5. PubMed ID: 16831287
[TBL] [Abstract][Full Text] [Related]
29. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
[TBL] [Abstract][Full Text] [Related]
30. A clinical and immunohistochemical study of gastrointestinal stromal tumours.
Khoo JJ; Gunn A
Malays J Pathol; 2005 Jun; 27(1):9-16. PubMed ID: 16676687
[TBL] [Abstract][Full Text] [Related]
31. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M
Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323
[TBL] [Abstract][Full Text] [Related]
32. High incidence of microscopic gastrointestinal stromal tumors in the stomach.
Kawanowa K; Sakuma Y; Sakurai S; Hishima T; Iwasaki Y; Saito K; Hosoya Y; Nakajima T; Funata N
Hum Pathol; 2006 Dec; 37(12):1527-35. PubMed ID: 16996566
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological and immunohistochemical features of extragastrointestinal stromal tumors: report of two cases.
Nakagawa M; Akasaka Y; Kanai T; Takabayashi T; Miyazawa N
Surg Today; 2005; 35(4):336-40. PubMed ID: 15815855
[TBL] [Abstract][Full Text] [Related]
34. "Seedling" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction.
Abraham SC; Krasinskas AM; Hofstetter WL; Swisher SG; Wu TT
Am J Surg Pathol; 2007 Nov; 31(11):1629-35. PubMed ID: 18059218
[TBL] [Abstract][Full Text] [Related]
35. Prediction of KIT mutation in gastrointestinal stromal tumors by the immunoprofile of the tumor cells.
Chou CC; Chou MJ; Tzen CY
J Formos Med Assoc; 2010 Jan; 109(1):25-31. PubMed ID: 20123583
[TBL] [Abstract][Full Text] [Related]
36. A histopathological review of gastrointestinal related mesenchymal tumors: the hidden GIST.
Issakov J; Jiveliouk I; Nachmany I; Klausner J; Merimsky O
Isr Med Assoc J; 2007 Nov; 9(11):810-2. PubMed ID: 18085040
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis and treatment of gastrointestinal stromal tumors: a study of 96 patients].
Lou YL; Chen H; Zhang XL; Zhan ZL
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):437-9. PubMed ID: 15355652
[TBL] [Abstract][Full Text] [Related]
38. Revision of gastrointestinal mesenchymal tumors.
Sornmayura P; Howannapakorn J; Karnsombut P
J Med Assoc Thai; 2009 Jan; 92(1):87-95. PubMed ID: 19260248
[TBL] [Abstract][Full Text] [Related]
39. The utility of fine-needle aspiration in the diagnosis of gastrointestinal stromal tumors: a cytomorphologic and immunohistochemical analysis with emphasis on malignant tumors.
Elliott DD; Fanning CV; Caraway NP
Cancer; 2006 Feb; 108(1):49-55. PubMed ID: 16130141
[TBL] [Abstract][Full Text] [Related]
40. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
